CN107693623A - A kind of Chinese medicine for reducing blood lipid - Google Patents

A kind of Chinese medicine for reducing blood lipid Download PDF

Info

Publication number
CN107693623A
CN107693623A CN201711019909.1A CN201711019909A CN107693623A CN 107693623 A CN107693623 A CN 107693623A CN 201711019909 A CN201711019909 A CN 201711019909A CN 107693623 A CN107693623 A CN 107693623A
Authority
CN
China
Prior art keywords
parts
chinese medicine
reducing blood
blood lipid
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711019909.1A
Other languages
Chinese (zh)
Inventor
路望培
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711019909.1A priority Critical patent/CN107693623A/en
Publication of CN107693623A publication Critical patent/CN107693623A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704Polygonum, e.g. knotweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/752Citrus, e.g. lime, orange or lemon

Abstract

The present invention relates to a kind of Chinese medicine for reducing blood lipid, and it is made up of each raw material of following parts by weight:30 50 parts of leech;20 40 parts of cassia seed;15 30 parts of cicada slough;10 20 parts of rheum officinale;17 34 parts of the fleece-flower root;25 45 parts of mountain bear gall;10 30 parts of the radix paeoniae rubrathe;15 25 parts of Fructus Aurantii;15 40 parts of balsam pear;10 20 parts of radix rehmanniae recen;12 24 parts of the red sage root.Compared with prior art, the beneficial effects of the invention are as follows:By carrying out screening combination and clinical test checking to a variety of antilipemic Chinese herbal medicine materials, the antilipemic Chinese herbal medicine of the present invention is obtained, it has preferable blood fat reducing function, and prescription is relatively easy, and medicinal material is common, cheap, has extraordinary popularizing value.

Description

A kind of Chinese medicine for reducing blood lipid
Technical field
The invention belongs to the field of Chinese medicines, and in particular to a kind of Chinese medicine for reducing blood lipid.
Background technology
Hyperlipidemia belongs to common disease in clinic, and with advancing age, its incidence of disease also substantially increases.Hyperlipidemia exists In artery sclerosis, coronary heart disease, the pathogenesis of obesity, play an important role, cause the common concern of people, China Public health service is included in the preventing and treating of cardiovascular and cerebrovascular disease, is put on an equal footing with Prevention of Infectious Diseases.
In the late two decades, substantial amounts of research work has been done in terms of medicine preventing and treating hyperlipidemia in use, has been hyperlipidemia New prospect has been opened up in research.With reference to modern means of science and technology such as doctors trained in Western medicine, in terms of Chinese medical discrimination basic research, theory of traditional Chinese medical science is to height Pionemia has new understanding, uses the report of traditional Chinese medicine prevention hyperlipidemia at present, has been directed to simple, compound, acupuncture, gas The many-sides such as work(, it is found that existing more than 60 kinds of Chinese herbal medicine has therapeutic action to hyperlipidemia, with Chinese and Western medicine curative effect comparative studies On the basis of filter out a collection of Cheng Fangyu folk prescriptions for having the symptom of a trend.
However, even so, can not still meet the needs of medical market.According to investigations, at present, existing eight million peoples of China are suffered from There is cardiovascular and cerebrovascular disease, and daily with the speed increase of 10,000 patients.Cardiovascular and cerebrovascular disease China it is worthy of the name turn into The leading killer of health is endangered, and hyperlipidemia is the major incentive of cardiovascular and cerebrovascular disease.Thus, develop curative for effect Drop (tune) fat medicine has turned into being needed when business for preventing and treating cardiovascular and cerebrovascular disease.
At present, it is more to treat the Chinese patent drug of hyperlipidemia, mainly has following several:
1. YunNan Pollen Tiendni Oral liquid:It is made up of pollen of Semen Fagopyri Esculenti, Typhonium flagelliforme (Lodd.) Blume, honey.Hemostasis for hyperlipidemia hinders Network is demonstrate,proved.
2. xinqingning tablet:It is made up of rheum officinale.Heat toxin inner product for hyperlipidemia is demonstrate,proved.
3. fat can be clear:It is made up of Roripa montana, radix scutellariae, hawthorn, rhizoma alismatis, rheum officinale, the banksia rose.For accumulateing in the phlegm wet of hyperlipidemia Card.
4. shou wu pian:It is made up of the tuber of multiflower knotweed.Syndrome of yin deficiency of liver and kidney for hyperlipidemia.
5. SHANZHAJING JIANGZHI PIAN:It is made up of Fructus Crataegi.For stagnant card in the food stasis of blood of hyperlipidemia.
6. fat-reducing health piece:It is made up of rhizoma alismatis.The insufficiency of the spleen with overabundance of dampness for hyperlipidemia is demonstrate,proved.
7. xinmaitong tablet:By Radix Angelicae Sinensis, cassia seed, yncaria stem with hooks, the root of bidentate achyranthes, the red sage root, the root of kudzu vine, sophora flower, Mao Keqing, Xia Jucao, pseudo-ginseng Composition.Syndrome of static blood blocking collaterals for hyperlipidemia.
8. Jiangzhiling Pian:It is made up of RADIX POLYGONI MULTIFLORI PREPARATA, cassia seed, sealwort, the banksia rose, hawthorn, the fruit of Cherokee rose, Ramulus Taxilli, rhizoma alismatis.For The syndrome of yin deficiency of liver and kidney of hyperlipidemia.
9. hypogastric lipid-lowering pill:By the red sage root, the tuber of multiflower knotweed, ginseng, sealwort, pseudo-ginseng, Ligusticum wallichii, Radix Angelicae Sinensis, rhizoma alismatis, barrenwort, cortex acanthopanacis, Chinese cassia tree forms.Deficiency of Yin stasis blocking for hyperlipidemia is demonstrate,proved.
Above medicine belongs to a bit cures the symptoms, not the disease, and some use expensive composition, some in application process by Cut in uncertain therapeutic efficacy and interrupt use.Therefore, a kind of curative for effect, safe ready, Small side effects, price are lacked in the prior art Cheap pure Chinese medicine compound medicine.
The content of the invention
The technical problems to be solved by the invention are to provide a kind of Chinese medicine for reducing blood lipid, it is desirable to provide a kind of curative effect is true Cut, safe ready, Small side effects, cheap pure Chinese medicine compound medicine.
The technical scheme that the present invention solves above-mentioned technical problem is as follows:A kind of Chinese medicine for reducing blood lipid, it is by following heavy Each raw material of amount number is made:Leech 30-50 parts;Cassia seed 20-40 parts;Cicada slough 15-30 parts;Rheum officinale 10-20 parts;The fleece-flower root 17-34 parts;Mountain bear gall 25-45 parts;Radix paeoniae rubrathe 10-30 parts;Fructus Aurantii 15-25 parts;Balsam pear 15-40 parts;Radix rehmanniae recen 10-20 parts;The red sage root 12-24 parts.
Preferably, the above-mentioned Chinese medicine for reducing blood lipid, it is made up of each raw material of following parts by weight:40 parts of leech;Certainly 30 parts of pine torch;20 parts of cicada slough;15 parts of rheum officinale;25 parts of the fleece-flower root;32 parts of mountain bear gall;20 parts of the radix paeoniae rubrathe;20 parts of Fructus Aurantii;30 parts of balsam pear; 12 parts of radix rehmanniae recen;16 parts of the red sage root.
Further, above-mentioned Chinese medicine is powdered that its particle diameter is 80-100 mesh.
Mountain bear gall, also known as iron holly bark, are born in the sparse woods on mountain valley, small stream side or hilly country, are distributed in Guangdong, Hainan, river The ground such as Soviet Union, Zhejiang, Taiwan, Fujian.Whole year can harvest, and strip bark, dry.The character of the medicine is:Drum or curling Long sheet, different in size, outer surface steel gray white, lark or taupe are coarse, often there is horizontal wrinkle and canescence patch;It is interior There is thin vertical wrinkle on surface, slightly smoothly, micro- tool gloss, sepia or dark brown.Matter is hard and crisp, broken, and section is slightly flat, slightly In graininess, yellowish-brown or sepia.Gas micro-perfume, bitter micro-puckery.With obvious effect for reducing blood fat, toxicity is low, Small side effects.
Leech:Xin Xianping, return liver warp, dissipating blood stasis with potent drugs.《This warp》" extravesated blood, hemostasis are controlled, is closed the moon, blood-breaking accumulation ... dredging water passages “.Because of disorder in ascending and descending, the turbid interior life of phlegm, mechanism of qi is checked, the not handsome blood of gas, the blood stasis of blood is stagnant, causes phlegm-blood stasis to fight and becomes trouble.When ascending the clear and descending the turbid, Product promoting blood circulation and removing blood stasis must be aided with.Therefore leech is adjutant.
Cassia seed:Salty put down is slightly cold.Return liver, large intestine channel.Heat-clearing improving eyesight, defaecation.《This warp》" main glaucoma, mesh are excessive, swelling ophthalmalgia, Lacrimation ".《Haigoushen》" except liver man heat ".《Book on Chinese herbal medicine is looked for the truth》" except it is interior radiating ".Phlegm-blood stasis is strongly fragrant long, then heat transformed from yang, assistant Cassia occidentalis it Be slightly cold it is light clear it, be adjutant.
The fleece-flower root:It is sweet, bitter, puckery, tepor.Return liver, the heart, kidney channel.Filling liver kidney, benefiting essence-blood, defaecation.《Detailed outline》" blood-nourishing benefit liver, Controlling nocturnal emission with astringent drugs kidney-nourishing, it is tonic medicine ".Hyperlipidemia is mainly in the elderly, comes to one's autumn, and kidney qi has declined, therefore is aided with the benefit of the tuber of multiflower knotweed Liver kidney, benefiting essence-blood think assistant.
Cicada slough:Sweet-salty, cold in nature, return lung, Liver Channel.Wind-dispelling heat-dissipating, promoting eruption is antipruritic, expels endogenous wind to relieve convulsion, removing nebula for improving eyesight.《Detailed outline》 " controlling phlegm-accumulating vertigo, skin pruritus, acne rash is had an itch, lockjaw and malignant boil pyogenic infections sore ".《Warm bar of trembling with fear is distinguished》" building residual air is obtained, is risen , the yang aspect of yang.Dispel see and win it is wet, wash heat and detoxify ".
Rheum officinale:Taste bitter and cold, returns spleen, stomach, large intestine, liver, pericardium channel.It is good at cleansing Gastrointestinal excess heat, removes constipation and stagnate, be Bitter cold captures key medicine.《This warp》" lower hemostasis, blood close fever and chills, break sign lump in the abdomen accumulation, stay drink place food, cleanse stomach and intestine, push away Chen Zhixin, lead to Sharp trough, helping digestion in tune, peace and the five internal organs ".《Detailed outline》" diarrhea is red white, inner colic, dribbling urination, real heat constipation, and hectic fever is raved Language, all fiery sores of jaundice ".
Compared with prior art, the beneficial effects of the invention are as follows:By carrying out screening combination to a variety of antilipemic Chinese herbal medicine materials Verified with clinical test, obtain the antilipemic Chinese herbal medicine of the present invention, it has preferable blood fat reducing function, and prescription is relatively easy, Medicinal material is common, cheap, has extraordinary popularizing value.
Embodiment
Technical scheme provided by the invention is described in further detail below in conjunction with specific embodiment, example is only For explaining the present invention, the scope of the present invention is not intended to limit.
Embodiment 1
A kind of Chinese medicine for reducing blood lipid, it is made up of each raw material of following parts by weight:40 parts of leech;Cassia seed 30 Part;20 parts of cicada slough;15 parts of rheum officinale;25 parts of the fleece-flower root;32 parts of mountain bear gall;20 parts of the radix paeoniae rubrathe;20 parts of Fructus Aurantii;30 parts of balsam pear;Radix rehmanniae recen 12 parts;16 parts of the red sage root.
Preparation method is to weigh each raw material (drying) according to parts by weight, be then milled, and crosses 80-100 mesh sieves, obtains powder, As described antilipemic Chinese herbal medicine.
Instructions of taking is to take 3-5g every time, is taken after mixing it with water with 30-50mL boiling water, for oral administration 1-2 times daily.
Embodiment 2
A kind of Chinese medicine for reducing blood lipid, it is made up of each raw material of following parts by weight:30 parts of leech;Cassia seed 20 Part;15 parts of cicada slough;10 parts of rheum officinale;17 parts of the fleece-flower root;25 parts of mountain bear gall;10 parts of the radix paeoniae rubrathe;15 parts of Fructus Aurantii;15 parts of balsam pear;Radix rehmanniae recen 10 parts;12 parts of the red sage root.
Preparation method is to weigh each raw material (drying) according to parts by weight, be then milled, and crosses 80-100 mesh sieves, obtains powder, As described antilipemic Chinese herbal medicine.
Instructions of taking is to take 3-5g every time, is taken after mixing it with water with 30-50mL boiling water, for oral administration 1-2 times daily.
Embodiment 3
A kind of Chinese medicine for reducing blood lipid, it is made up of each raw material of following parts by weight:50 parts of leech;Cassia seed 40 Part;30 parts of cicada slough;20 parts of rheum officinale;34 parts of the fleece-flower root;45 parts of mountain bear;30 parts of the radix paeoniae rubrathe;25 parts of Fructus Aurantii;40 parts of balsam pear;Radix rehmanniae recen 20 Part;24 parts of the red sage root.
Preparation method is to weigh each raw material (drying) according to parts by weight, be then milled, and crosses 80-100 mesh sieves, obtains powder, As described antilipemic Chinese herbal medicine.
Instructions of taking is to take 3-5g every time, is taken after mixing it with water with 30-50mL boiling water, for oral administration 1-2 times daily.
Clinical test shows that antilipemic Chinese herbal medicine provided by the invention has good effect for reducing blood fat, continuously takes January, Not it was observed that obvious side effect.
The foregoing is only presently preferred embodiments of the present invention, be not intended to limit the invention, it is all the present invention spirit and Within principle, any modification, equivalent substitution and improvements made etc., it should be included in the scope of the protection.

Claims (3)

1. a kind of Chinese medicine for reducing blood lipid, it is characterised in that be made up of each raw material of following parts by weight:Leech 30-50 parts; Cassia seed 20-40 parts;Cicada slough 15-30 parts;Rheum officinale 10-20 parts;Fleece-flower root 17-34 parts;Mountain bear gall 25-45 parts;Radix paeoniae rubrathe 10-30 Part;Fructus Aurantii 15-25 parts;Balsam pear 15-40 parts;Radix rehmanniae recen 10-20 parts;Red sage root 12-24 parts.
2. a kind of Chinese medicine for reducing blood lipid according to claim 1, it is characterised in that by each original of following parts by weight Material is made:40 parts of leech;30 parts of cassia seed;20 parts of cicada slough;15 parts of rheum officinale;25 parts of the fleece-flower root;32 parts of mountain bear gall;20 parts of the radix paeoniae rubrathe; 20 parts of Fructus Aurantii;30 parts of balsam pear;12 parts of radix rehmanniae recen;16 parts of the red sage root.
A kind of 3. Chinese medicine for reducing blood lipid according to claim 1, it is characterised in that the Chinese medicine to be powdered, its Particle diameter is 80-100 mesh.
CN201711019909.1A 2017-10-27 2017-10-27 A kind of Chinese medicine for reducing blood lipid Pending CN107693623A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711019909.1A CN107693623A (en) 2017-10-27 2017-10-27 A kind of Chinese medicine for reducing blood lipid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711019909.1A CN107693623A (en) 2017-10-27 2017-10-27 A kind of Chinese medicine for reducing blood lipid

Publications (1)

Publication Number Publication Date
CN107693623A true CN107693623A (en) 2018-02-16

Family

ID=61182237

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711019909.1A Pending CN107693623A (en) 2017-10-27 2017-10-27 A kind of Chinese medicine for reducing blood lipid

Country Status (1)

Country Link
CN (1) CN107693623A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1440804A (en) * 2003-03-31 2003-09-10 江西汇仁药业有限公司 Antilipemic Chinese medicine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1440804A (en) * 2003-03-31 2003-09-10 江西汇仁药业有限公司 Antilipemic Chinese medicine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王世宏: "自制活血降脂合剂治疗高脂血症52例", 《安徽中医临床杂志》 *

Similar Documents

Publication Publication Date Title
CN107303383A (en) A kind of Chinese medicine composition and its derivative and product to a variety of symptoms with effect
CN108029821A (en) Bark of eucommia solid health-care tea and preparation method thereof
CN104587298A (en) Traditional Chinese medicinal composition for treating pulmonary abscess
CN101642523A (en) Chinese patent medicine for treating cardiovascular and cerebrovascular diseases
CN104082745A (en) Medicated food for conditioning blood-stasis constitution and improving immune adjustment capability and preparation method of medicated food
CN1127967C (en) Quick-acting hypertension capsule
CN102302733B (en) Oral Chinese medicinal composition for treating ovarian cyst
CN103393986B (en) Traditional Chinese medicine composition for treating hepatitis b cirrhosis and preparation method thereof
CN105435197A (en) Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof
CN103100036A (en) Traditional Chinese medicine (TCM) preparation for treating intercostal neuralgia
CN104353051A (en) Traditional Chinese medicine preparation for treating stomachache and preparation method thereof
CN103705881A (en) Honey pill for treating epigastric pain and preparation method thereof
CN107693623A (en) A kind of Chinese medicine for reducing blood lipid
CN102327533A (en) Chinese herbal medicine for treating earliest scrofula
CN103463427B (en) Medicinal tea for treating arteriosclerosis
CN103028076B (en) Traditional Chinese medicine composition for treating liver cirrhosis
CN105596629A (en) Traditional Chinese medicinal pill for treating gynopathy, and preparation method thereof
CN105853978A (en) Method for preparing medicinal composition for treating female climacteric syndrome
CN104547875A (en) Traditional Chinese medicine for treating arteries and veins stasis type chest stuffiness and pain
CN102327468A (en) Chinese herbal medicine for treating qi-blood deficiency induced insomnia
CN1319415A (en) Pill medicine for treating cardio-cerebro vascular diseases
CN102488804A (en) Traditional Chinese medicine for treating cirrhosis
CN102309725B (en) Traditional Chinese medicine preparation for treating hepatitis B cirrhosis and preparation method
CN100381149C (en) Chinese medicinal capsule for treating breast phymatosis
CN102018943A (en) Oral Chinese patent medicinal capsules for treating middle and old-aged white hair

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180216

RJ01 Rejection of invention patent application after publication